CBP anticorps (AA 2217-2442)
-
- Antigène Voir toutes CBP (CREBBP) Anticorps
- CBP (CREBBP) (CREB Binding Protein (CREBBP))
-
Épitope
- AA 2217-2442
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CBP est non-conjugé
-
Application
- Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
- Réactivité croisée
- Humain
- Purification
- >95%, Protein G purified
- Immunogène
- Recombinant Human CREB-binding protein (2217-2442AA)
- Isotype
- IgG
- Top Product
- Discover our top product CREBBP Anticorps primaire
-
anti-CREB Binding Protein (CREBBP) (C-Term) antibody
KO Validated CREBBP Reactivité: Humain WB, IF, IP, IHC (p), ICC, ChIP Hôte: Lapin Polyclonal unconjugated
anti-CREB Binding Protein (CREBBP) (C-Term) antibodyCREBBP Reactivité: Humain, Souris, Rat WB, IHC, ELISA, IF, ICC Hôte: Lapin Polyclonal unconjugated
anti-CREB Binding Protein (CREBBP) (AA 951-1050) antibodyCREBBP Reactivité: Humain WB, ELISA, IF, PLA Hôte: Souris Monoclonal 2H5 unconjugated
anti-CREB Binding Protein (CREBBP) (AA 1000-1100) antibody (Atto 594)CREBBP Reactivité: Humain WB, IHC Hôte: Lapin Polyclonal Atto 594
anti-CREB Binding Protein (CREBBP) (AA 1000-1100) antibody (Atto 390)CREBBP Reactivité: Humain WB, IHC Hôte: Lapin Polyclonal Atto 390
anti-CREB Binding Protein (CREBBP) (AA 1000-1100) antibody (HRP)CREBBP Reactivité: Humain WB, IHC Hôte: Lapin Polyclonal HRP
anti-CREB Binding Protein (CREBBP) (AA 1000-1100) antibody (FITC)CREBBP Reactivité: Humain WB, IHC Hôte: Lapin Polyclonal FITC
anti-CREB Binding Protein (CREBBP) (AA 1000-1100) antibody (Biotin)CREBBP Reactivité: Humain WB, IHC Hôte: Lapin Polyclonal Biotin
anti-CREB Binding Protein (CREBBP) (AA 1000-1100) antibody (PE)CREBBP Reactivité: Humain WB, IHC Hôte: Lapin Polyclonal PE
anti-CREB Binding Protein (CREBBP) (AA 144-193) antibodyCREBBP Reactivité: Humain, Souris, Rat, Boeuf (Vache), Chien, Poulet, Cobaye, Cheval, Lapin WB, IHC, IHC (p) Hôte: Lapin Polyclonal unconjugated
-
- Indications d'application
- Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- CBP (CREBBP) (CREB Binding Protein (CREBBP))
- Autre désignation
- CREBBP (CREBBP Produits)
- Synonymes
- anticorps CBP, anticorps KAT3A, anticorps RSTS, anticorps AW558298, anticorps CBP/p300, anticorps p300/CBP, anticorps RTS, anticorps cbp, anticorps crebbp, anticorps kat3a, anticorps rsts, anticorps hmm291030, anticorps Nejire, anticorps CREB binding protein, anticorps CREB binding protein L homeolog, anticorps histone acetyltransferase p300, anticorps CREBBP, anticorps Crebbp, anticorps crebbp.L, anticorps LOC100123220
- Sujet
-
Background: Acetylates histones, giving a specific tag for transcriptional activation. Also acetylates non-histone proteins, like NCOA3 and FOXO1. Binds specifically to phosphorylated CREB and enhances its transcriptional activity toward cAMP-responsive genes. Acts as a coactivator of ALX1. Acts as a circadian transcriptional coactivator which enhances the activity of the circadian transcriptional activators: NPAS2-ARNTL/BMAL1 and CLOCK-ARNTL/BMAL1 heterodimers. Acetylates PCNA, acetylation promotes removal of chromatin-bound PCNA and its degradation during nucleotide excision repair (NER) (PubMed:24939902).
Aliases: CBP antibody, CBP_HUMAN antibody, CREB binding protein antibody, CREB-binding protein antibody, Crebbp antibody, Cyclic AMP responsive enhancer binding protein antibody, KAT3A antibody, RSTS antibody, RTS antibody, Rubinstein Taybi syndrome antibody
- UniProt
- Q92793
- Pathways
- TCR Signaling, Interferon-gamma Pathway, Stem Cell Maintenance, Chromatin Binding, Regulation of Lipid Metabolism by PPARalpha
-
